Intelligent Change In Cash from 2010 to 2025

INBS Stock  USD 1.76  0.18  11.39%   
Intelligent Bio Change In Cash yearly trend continues to be comparatively stable with very little volatility. Change In Cash is likely to outpace its year average in 2025. From the period from 2010 to 2025, Intelligent Bio Change In Cash quarterly data regression had mean square error of 17.4 T and mean deviation of  2,664,151. View All Fundamentals
 
Change In Cash  
First Reported
2018-06-30
Previous Quarter
-3.1 M
Current Value
-2.3 M
Quarterly Volatility
4.7 M
 
Covid
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 142.9 K or Selling General Administrative of 11.2 M, as well as many indicators such as Price To Sales Ratio of 1.02, Dividend Yield of 0.0 or PTB Ratio of 0.33. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
  
Check out the analysis of Intelligent Bio Correlation against competitors.

Latest Intelligent Bio's Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Intelligent Bio Solutions over the last few years. It is Intelligent Bio's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Pretty Stable
   Change In Cash   
       Timeline  

Intelligent Change In Cash Regression Statistics

Arithmetic Mean1,098,726
Coefficient Of Variation374.89
Mean Deviation2,664,151
Median362,387
Standard Deviation4,118,998
Sample Variance17T
Range18.8M
R-Value0.21
Mean Square Error17.4T
R-Squared0.04
Significance0.44
Slope181,070
Total Sum of Squares254.5T

Intelligent Change In Cash History

20254.5 M
20244.3 M
20234.8 M
2022-6.7 M
2021-4.3 M
202012.1 M
2019229.3 K

About Intelligent Bio Financial Statements

Intelligent Bio shareholders use historical fundamental indicators, such as Change In Cash, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change In Cash4.3 M4.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.